S
Sohan Deshpande
Researcher at York University
Publications - 29
Citations - 3256
Sohan Deshpande is an academic researcher from York University. The author has contributed to research in topics: Systematic review & Cost effectiveness. The author has an hindex of 16, co-authored 26 publications receiving 2616 citations.
Papers
More filters
Journal ArticleDOI
A systematic review to assess adherence and persistence with statins.
Sohan Deshpande,Ruben G.W. Quek,Carol A. Forbes,Shelley de Kock,Jos Kleijnen,Shravanthi R. Gandra,Ross J. Simpson +6 more
TL;DR: There was limited evidence to suggest that high intensity statin regimens are associated with poorer treatment adherence when compared to lower intensity regimens, and more robust studies are required to establish this association.
Journal ArticleDOI
Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
Peter P. Toth,Gillian Worthy,Shravanthi R. Gandra,Naveed Sattar,Sarah Bray,L Cheng,Ian Bridges,G Worth,Ricardo Dent,Carol A. Forbes,Sohan Deshpande,Janine Ross,Jos Kleijnen,Erik S.G. Stroes +13 more
TL;DR: A systematic review and network meta‐analysis of randomized trials of lipid‐lowering therapies showed a significant treatment difference in LDL‐C reduction for evolocumab versus alirocumab, and PCSK9 inhibitors added to medium‐ to high‐intensity statin therapy significantly reduce LDL‐ c reduction in patients requiring further LDL-C reduction.
Cost-effectiveness analysis
Nigel Armstrong,Laura Burgers,Sohan Deshpande,Maiwenn Al,Rob Riemsma,SR Vallabhaneni,Peter Holt,Johan L. Severens,Jos Kleijnen +8 more
Journal ArticleDOI
The relationship between Lp(a) and CVD outcomes: a systematic review
Carol A. Forbes,Ruben G.W. Quek,Sohan Deshpande,Gill Worthy,Robert Wolff,Lisa Stirk,Jos Kleijnen,Shravanthi R. Gandra,Stephen Djedjos,Nathan D. Wong +9 more
TL;DR: Current evidence would suggest that increased Lp(a) levels are associated with modest increases in the risk of future CVD events in both general and higher risk populations, but further studies are required to confirm these findings.
Journal ArticleDOI
SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
R Riemsma,Maiwenn Al,I. Corro Ramos,Sohan Deshpande,Nigel Armstrong,Y-C Lee,Steve Ryder,Caro Noake,Marieke Krol,Mark Oppe,Jos Kleijnen,Hans Severens +11 more
TL;DR: A systematic review was conducted to summarise the evidence on the clinical effectiveness of Se HCAT for the assessment of BAM and the measurement of bile acid pool loss and found three studies assessing the relationship between the SeHCAT test and response to treatment with cholestyramine.